BOSTON SCIENTIFIC CORPORATION Accounts Payable
BOSTON SCIENTIFIC CORPORATION (BSX) had Accounts Payable of $1.23 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-03
- 2026-06-30: Accounts Payable, Current $1.23B.
- 2026-03-31: Accounts Payable, Current $1.14B.
- 2025-12-31: Accounts Payable, Current $1.14B.
- 2025-09-30: Accounts Payable, Current $1.00B.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.23B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.14B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $1.14B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $1.00B 10-Q · filed 2025-11-03 |
| 2025-06-30 | $962.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $1.00B 10-Q · filed 2025-05-01 |
| 2024-12-31 | $960.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $907.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $906.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $921.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $942.00M 10-K · filed 2025-02-18 |
| 2023-09-30 | $929.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $899.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $868.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $862.00M 10-K · filed 2024-02-20 |
| 2022-09-30 | $803.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $732.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $696.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $794.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $674.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $689.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $615.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $513.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | $452.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $408.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $605.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $542.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | $512.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $524.00M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $498.00M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $349.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | $453.00M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $403.00M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $404.00M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $530.00M 10-K · filed 2019-02-19 |
| 2017-09-30 | $371.00M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $376.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $376.00M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $447.00M 10-K · filed 2018-02-20 |
| 2016-09-30 | $298.00M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $284.00M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $232.00M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $209.00M 10-K · filed 2017-02-23 |
| 2015-09-30 | $210.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $191.00M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $228.00M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $262.00M 10-K · filed 2016-02-24 |
| 2014-09-30 | $234.00M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $241.00M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $241.00M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $246.00M 10-K · filed 2015-02-25 |
| 2013-09-30 | $238.00M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $251.00M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $206.00M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $232.00M 10-K · filed 2014-02-26 |
| 2012-09-30 | $228.00M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $263.00M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $288.00M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $203.00M 8-K · filed 2013-05-29 |
| 2011-09-30 | $256.00M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $223.00M 10-Q · filed 2011-08-05 |
| 2011-03-31 | $217.00M 10-Q · filed 2011-05-05 |
| 2010-12-31 | $184.00M 10-K · filed 2012-02-17 |
| 2010-09-30 | $195.00M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $180.00M 10-Q · filed 2010-08-05 |
| 2010-03-31 | $232.00M 10-Q · filed 2010-05-06 |
| 2009-12-31 | $212.00M 10-K · filed 2011-02-17 |
| 2009-09-30 | $225.00M 10-Q · filed 2009-11-06 |
| 2009-06-30 | $213.00M 10-Q · filed 2009-08-06 |
| 2008-12-31 | $239.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |